Wordt geladen...
Exploratory in vitro evaluation of thrombin generation of eptacog beta (recombinant human fviia) and emicizumab in congenital haemophilia A plasma
INTRODUCTION/AIM: Eptacog beta is a recombinant activated human factor VII approved to treat and control bleeding in haemophilia A and B patients with inhibitors. Emicizumab is a factor VIIIa mimetic antibody approved for prophylactic treatment of haemophilia A with and without inhibitors (HAI and H...
Bewaard in:
| Gepubliceerd in: | Haemophilia |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8048629/ https://ncbi.nlm.nih.gov/pubmed/33550714 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hae.14253 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|